메뉴 건너뛰기
Transplantation Proceedings
Volumn 45, Issue 9, 2013, Pages 3325-3328
Sirolimus reduces the risk of significant hepatic fibrosis after liver transplantation for Hepatitis C virus: A single-center experience
Author keywords

[No Author keywords available]
Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;
EID: 84887033309     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.04.011     Document Type: Article
Times cited : (16)
References (8)
  • 1
    • 0032738763 scopus 로고    scopus 로고
    • Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis
    • J. Zhu, J. Wu, and E. Frizell Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis Gastroenterology 117 1999 1198 1204
    • (1999) Gastroenterology , vol.117 , pp. 1198-1204
    • Zhu, J.1    Wu, J.2    Frizell, E.3
  • 2
    • 70350532016 scopus 로고    scopus 로고
    • Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways
    • K.R. Bridle, C. Popa, and M.L. Morgan Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways Liver Transpl 15 2009 1315 1324
    • (2009) Liver Transpl , vol.15 , pp. 1315-1324
    • Bridle, K.R.1    Popa, C.2    Morgan, M.L.3
  • 3
    • 33750433893 scopus 로고    scopus 로고
    • Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis
    • M. Neef, M. Ledermann, and H. Saegesser Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis J Hepatol 45 2006 786 796
    • (2006) J Hepatol , vol.45 , pp. 786-796
    • Neef, M.1    Ledermann, M.2    Saegesser, H.3
  • 4
    • 17144377431 scopus 로고    scopus 로고
    • The role of p70S6K in hepatic stellate cell collagen gene expression and cell proliferation
    • E. Gabele, S. Reif, and S. Tsukada The role of p70S6K in hepatic stellate cell collagen gene expression and cell proliferation J Biol Chem 280 2005 13374 13382
    • (2005) J Biol Chem , vol.280 , pp. 13374-13382
    • Gabele, E.1    Reif, S.2    Tsukada, S.3
  • 5
    • 0028869086 scopus 로고
    • Rapamune (sirolimus, rapamycin): An overview and mechanism of action
    • S.N. Sehgal Rapamune (sirolimus, rapamycin): an overview and mechanism of action Ther Drug Monit 17 1995 660 665
    • (1995) Ther Drug Monit , vol.17 , pp. 660-665
    • Sehgal, S.N.1
  • 6
    • 83555164165 scopus 로고    scopus 로고
    • Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression
    • G.J. McKenna, J.F. Trotter, and E. Klintmalm Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression Am J Transplant 11 2011 2379 2387
    • (2011) Am J Transplant , vol.11 , pp. 2379-2387
    • McKenna, G.J.1    Trotter, J.F.2    Klintmalm, E.3
  • 7
    • 79952265424 scopus 로고    scopus 로고
    • The impact of sirolimus on hepatitis C recurrence after liver transplantation
    • S. Asthana, C. Toso, and G. Meeberg The impact of sirolimus on hepatitis C recurrence after liver transplantation Can J Gastroenterol 25 2011 28 34
    • (2011) Can J Gastroenterol , vol.25 , pp. 28-34
    • Asthana, S.1    Toso, C.2    Meeberg, G.3
  • 8
    • 78751644737 scopus 로고    scopus 로고
    • Switching to sirolimus-based immune suppression after liver transplantation is safe and effective: A single-center experience
    • S.J. Harper, W. Gelson, and I.G. Harper Switching to sirolimus-based immune suppression after liver transplantation is safe and effective: a single-center experience Transplantation 91 2011 128 132
    • (2011) Transplantation , vol.91 , pp. 128-132
    • Harper, S.J.1    Gelson, W.2    Harper, I.G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.